What is it about?
It sheds light on the antibacterial potential of adipose-derived mesenchymal stromal cell (AD-MSC) secretome against clinical isolates of Staphylococcus spp., including MRSA strains.
Featured Image
Why is it important?
It is important because it emphasizes the ability of AD-MSCs secretome as a promising alternative for treating antibiotic-resistant infections, with potential applications in combating MRSA.
Perspectives
The utilization of mesenchymal stem cells and especially their secretome in combating bacterial infections, particularly against challenging pathogens like methicillin-resistant Staphylococcus aureus (MRSA), represents a fascinating area of research with significant therapeutic potential.
Fatima Saleh
Beirut Arab University
Read the Original
This page is a summary of: Antimicrobial activity of adipose-derived mesenchymal stromal cell secretome against methicillin-resistant Staphylococcus aureus, Stem Cell Research & Therapy, January 2025, Springer Science + Business Media,
DOI: 10.1186/s13287-025-04138-3.
You can read the full text:
Contributors
The following have contributed to this page
